These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23406802)

  • 21. Ablative therapies in the treatment of small renal tumors: how far from standard of care?
    Gontero P; Joniau S; Zitella A; Tailly T; Tizzani A; Van Poppel H; Kirkali Z
    Urol Oncol; 2010; 28(3):251-9. PubMed ID: 19897385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of small renal masses.
    Kunkle DA; Kutikov A; Uzzo RG
    Semin Ultrasound CT MR; 2009 Aug; 30(4):352-8. PubMed ID: 19711645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimally invasive nephron sparing management for renal tumors in solitary kidneys.
    Turna B; Kaouk JH; Frota R; Stein RJ; Kamoi K; Gill IS; Novick AC
    J Urol; 2009 Nov; 182(5):2150-7. PubMed ID: 19758655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of laparoscopy and robotic surgery in the management of small renal masses.
    Hrouda D; Lienert A
    Expert Rev Anticancer Ther; 2012 Jun; 12(6):799-810. PubMed ID: 22716496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency ablation for treatment of renal tumors: technological principles and outcomes.
    Salas N; Castle SM; Leveillee RJ
    Expert Rev Med Devices; 2011 Nov; 8(6):695-707. PubMed ID: 22029467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy.
    Nguyen CT; Lane BR; Kaouk JH; Hegarty N; Gill IS; Novick AC; Campbell SC
    J Urol; 2008 Jul; 180(1):104-9; discussion 109. PubMed ID: 18485401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal ablative therapy: radiofrequency ablation and cryoablation.
    Raman JD; Hall DW; Cadeddu JA
    J Surg Oncol; 2009 Dec; 100(8):639-44. PubMed ID: 20017159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New approaches to the minimally invasive treatment of kidney tumors.
    Trabulsi EJ; Kalra P; Gomella LG
    Cancer J; 2005; 11(1):57-63. PubMed ID: 15831225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New technologies for ablation of small renal tumors: current status.
    Chin JL; Pautler SE
    Can J Urol; 2002 Aug; 9(4):1576-82. PubMed ID: 12243653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Do ablative treatments modify the management of kidney tumors in the elderly?].
    Long JA; Neuzillet Y; Poissonnier L; Lang H; Paparel P; Escudier B; Rioux-Leclercq N; Correas JM; Mejean A; Baumert H; Soulié M; Patard JJ
    Prog Urol; 2009 Nov; 19 Suppl 3():S116-23. PubMed ID: 20123494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques.
    Raman JD; Raj GV; Lucas SM; Williams SK; Lauer EM; Ahrar K; Matin SF; Leveillee RJ; Cadeddu JA
    BJU Int; 2010 Feb; 105(4):496-500. PubMed ID: 19681900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Indications for ablative treatment in kidney cancer in the elderly].
    Froger L; Neuzillet Y; Lebret T
    Prog Urol; 2012 Dec; 22(16):1004-9. PubMed ID: 23178096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimally invasive surgery for renal cell carcinoma.
    Ghoneim IA; Fergany AF
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):989-97. PubMed ID: 19589037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does renal mass ablation provide adequate long-term oncologic control?
    Faddegon S; Cadeddu JA
    Urol Clin North Am; 2012 May; 39(2):181-90, vi. PubMed ID: 22487761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Minimal invasive approach to renal cancer].
    Hidas G; Shental J; Nativ O
    Harefuah; 2005 May; 144(5):347-50, 382, 381. PubMed ID: 15931899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is radiofrequency ablation safe for solitary kidneys?
    Jacobsohn KM; Ahrar K; Wood CG; Matin SF
    Urology; 2007 May; 69(5):819-23; discussion 823. PubMed ID: 17482911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidney cancer ablative therapy: indications and patient selection.
    Lehman DS; Landman J
    Curr Urol Rep; 2008 Jan; 9(1):34-43. PubMed ID: 18366972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current role of image-guided ablative therapies in lung cancer.
    Simon CJ; Dupuy DE
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):657-66. PubMed ID: 16111466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retroperitoneoscopic-guided radiofrequency ablation of renal tumors.
    Pautler SE; Pavlovich CP; Mikityansky I; Drachenberg DE; Choyke PL; Linehan WM; Wood BJ; Walther MM
    Can J Urol; 2001 Aug; 8(4):1330-3. PubMed ID: 11564277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Image-guided percutaneous ablation of renal tumors: outcomes, technique, and application in urologic practice.
    Mues AC; Landman J
    Curr Urol Rep; 2010 Feb; 11(1):8-14. PubMed ID: 20425631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.